Close
American Drug Delivery & Formulation Summit
Xylem

Eppendorf and Florida State University Collaboration Demonstrates Large-Scale Stem Cell Expansion

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Shilpa Biologicals Launches Integrated ADC Production Site in India

Shilpa Biologicals Ltd, a subsidiary of Shilpa Medicare Ltd,...

CPHI Milan 2026 Unveils Dedicated Innovation Hubs for Pharma Manufacturing

CPHI Milan 2026, recognized as a premier global gathering...

Sanofi Partners with Pangaea for AI-Driven AATD Detection

Pangaea Data (Pangaea), a provider of a guideline-configured AI...
- Advertisement -

A collaboration between Eppendorf and Florida State University has successfully shown the feasibility of large-scale expansion of human mesenchymal stem cells (MSC) using the company’s proprietary Fibra-Cel packed-bed technology.

Eppendorf Technical Applications director Dr Ma Sha provided equipment and funding for reagents to Dr Teng Ma to support the Florida State team’s work in the field of stem cell expansion.

The team successfully conducted MSC expansion inside a packed-bed 3D matrix using a CelliGen 310 bioreactor at 2L scale.

Results demonstrate the feasibility of large-scale stem cell expansion using Fibra-Cel packed-bed technology, which provides uniform mass transfer of nutrients and oxygen to the adhered cells.

Findings will be submitted for publication at a peer reviewed scientific journal.

College of Engineering professor Dr Yaw D Yeboah thanked Eppendorf and noted the company’s commitment to the university allows it to continue to deliver world-class education and transformative experiences.

ย 

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Shilpa Biologicals Launches Integrated ADC Production Site in India

Shilpa Biologicals Ltd, a subsidiary of Shilpa Medicare Ltd,...

CPHI Milan 2026 Unveils Dedicated Innovation Hubs for Pharma Manufacturing

CPHI Milan 2026, recognized as a premier global gathering...

Sanofi Partners with Pangaea for AI-Driven AATD Detection

Pangaea Data (Pangaea), a provider of a guideline-configured AI...

Shilpa Biologicals Launches PartnerPower Platform for CDMOs

Shilpa Biologicals Pvt. Ltd. (SBPL) has introduced PartnerPower Platform,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป